[Analysis of pharmaceutical care in dispensing of over-the-counter orlistat].
Obesity is a chronic disease characterized by its high prevalence. Easy availability of pharmaceutical care allows pharmacies to be the first place of capture or intervention for patients who are overweight or obese. The aim of the study was to analyse the role of pharmacists and pharmacy technicians in securing the safety of self-medication with orlistat. In this prospective observational study, the patients were the people who came to the IKEM Hospital Pharmacy for self-medication with orlistat over a period of May through December 2009. The data were collected by trained pharmacists and pharmacy technicians in interviews with patients when dispensing over-the-counter (OTC) orlistat. The interview was designed by fixed questions. The results were analysed using frequency analysis, GLMz and the chi-square test with the level of significance of p < 0.05. A total of 50 patients participated in the study (44 women, median age 53 years, 41 patients with body mass index > 28). 58% patients were fully indicated for self-medication with orlistat. Self-medication with orlistat was recommended to 48% patients and was refused to 22% patients because of contraindications. 24% patients had at least one interaction with orlistat and chronic drugs. Health problems were the most common motivation for weight reduction. The data obtained in this study demonstrate an important role of pharmacists and pharmacy technicians in the assessment of suitability of self-medication with OTC orlistat and safe weight reduction within self-medication.